Girona FC renews its agreement with HYLO\u00ae<\/figcaption><\/p>\n<\/figure>\nGirona FC has renewed its agreement with Brill Pharma, the pharmaceutical company responsible for the distribution in Spain of the HYLO\u00ae range, which belongs to the prestigious German group Ursapharm, for a further three seasons. The HYLO\u00ae brand will remain on the sleeve of the playing shirt in a historic campaign for the Club, which will compete in the Champions League. This milestone not only underlines the level of sporting success achieved by Girona FC, but also provides an unrivalled platform for the promotion of HYLO\u00ae and Brill Pharma on an international level.<\/p>\n
This strategic partnership will not only bring significant benefits for the Club, but will also increase the visibility of the HYLO\u00ae and Brill Pharma brand in the dynamic world of football and among the passionate fans of Girona FC.<\/p>\n
The renewal of this agreement reaffirms Girona FC’s commitment to excellence and its willingness to collaborate with market-leading brands. HYLO\u00ae, renowned for its effectiveness in eye care, has established itself as the reference in dry eyes in Spain, and this strategic alliance will further strengthen its presence in the sports sector.<\/p>\n
The partnership between Girona FC and Brill Pharma is a clear demonstration of the mutual commitment to excellence and innovation. We are confident that this collaboration will continue to be fruitful and beneficial for both parties, contributing to the success of the Club and the growth of the HYLO\u00ae brand in the market.<\/p>\n
About Brill Pharma<\/strong><\/p>\nBrill Pharma is a leading Spanish pharmaceutical company specialising in ophthalmic products. As the exclusive distributor of the HYLO\u00ae range in Spain, Brill Pharma is dedicated to providing innovative and effective eye care solutions.<\/p>\n
About HYLO\u00ae<\/strong><\/p>\nHYLO\u00ae is the leading brand in the treatment of dry eyes, offering high quality products that soothe and protect dry eyes. Owned by the German Ursapharm Group, HYLO\u00ae has established itself as a market leader thanks to its efficacy and safety.<\/p>\n<\/div>\n
Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Girona FC renews its agreement with HYLO® Girona FC has renewed its agreement with Brill Pharma, the pharmaceutical company responsible for theRead More ›<\/a><\/button><\/p>\n","protected":false},"author":1,"featured_media":32251,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":""},"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/newssprinters.com\/index.php\/wp-json\/wp\/v2\/posts\/32249"}],"collection":[{"href":"https:\/\/newssprinters.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newssprinters.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newssprinters.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newssprinters.com\/index.php\/wp-json\/wp\/v2\/comments?post=32249"}],"version-history":[{"count":0,"href":"https:\/\/newssprinters.com\/index.php\/wp-json\/wp\/v2\/posts\/32249\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newssprinters.com\/index.php\/wp-json\/wp\/v2\/media\/32251"}],"wp:attachment":[{"href":"https:\/\/newssprinters.com\/index.php\/wp-json\/wp\/v2\/media?parent=32249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newssprinters.com\/index.php\/wp-json\/wp\/v2\/categories?post=32249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newssprinters.com\/index.php\/wp-json\/wp\/v2\/tags?post=32249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}